NeuroQure

NeuroQure NeuroQure is revolutionizing autism detection with a first-of-its-kind autism risk test.

Excited to be a part of the Profound Autism Summit! We’re looking forward to sharing how biology- based insights can hel...
04/08/2026

Excited to be a part of the Profound Autism Summit! We’re looking forward to sharing how biology- based insights can help inform earlier understanding of autism risk and support more proactive care.

Waiting for autism's behavioral symptoms to appear isn't the only option anymore. A breakthrough calcium signaling biomarker can detect ASD risk from infancy — with accuracy comparable to the ADOS based on company data. Jill S. Dolinsky, VP of Medical Sciences at NeuroQure, will explore how this could redefine developmental monitoring, early intervention and family counseling. Don't miss this session at the Profound Autism Summit! There's still time to register for in-person or the virtual option! Go to profoundautismsummit.org or the link in our bio.

.lab .aba

Autism touches people of all ages: individuals, families, caregivers, and communities. Acceptance means creating space f...
04/08/2026

Autism touches people of all ages: individuals, families, caregivers, and communities.

Acceptance means creating space for clearer insight, earlier awareness, and more informed support at every stage of the journey.

Many families spend years navigating uncertainty before receiving an autism diagnosis for their child.Our mission is to ...
04/06/2026

Many families spend years navigating uncertainty before receiving an autism diagnosis for their child.

Our mission is to bring forward science-based insights that can help individuals, families, and clinicians better understand developmental pathways earlier.

Earlier insight into autism risk can help reduce uncertainty and support next steps sooner.

April is  . We believe acceptance starts with understanding. To us, that means supporting people with compassion, expand...
04/02/2026

April is . We believe acceptance starts with understanding.

To us, that means supporting people with compassion, expanding access to information, and continuing to advance the science that helps clinicians better understand neurodevelopment. 💙

For parents, early answers can mean everything. ASD Insight™ offers a path to earlier intervention during this important...
02/25/2026

For parents, early answers can mean everything. ASD Insight™ offers a path to earlier intervention during this important developmental window.

We’re here to support families with finding science-backed answers to make informed decisions about their child’s path.

Launching ASD Insight™ is just the beginning.Our vision is to transform neurodevelopmental care, bringing rigorous scien...
02/09/2026

Launching ASD Insight™ is just the beginning.

Our vision is to transform neurodevelopmental care, bringing rigorous science, compassionate support, and innovative tools to families everywhere.

We’re grateful to the scientists, clinicians, families, and partners who’ve helped bring this test to life.

neuroqure.com?utm_source=facebook&utm_campaign=launch_organic&utm_medium=social

Read Fierce Biotech’s take on how ASD Insight™ brings biology-based autism risk detection into the earliest stages of ca...
02/06/2026

Read Fierce Biotech’s take on how ASD Insight™ brings biology-based autism risk detection into the earliest stages of care:

NeuroQure, a startup diagnostics medtech that formed in 2023, has launched a

Our founding scientist, John Jay Gargus MD, PhD, discusses the science behind ASD Insight™ with Healio:
02/05/2026

Our founding scientist, John Jay Gargus MD, PhD, discusses the science behind ASD Insight™ with Healio:

Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a skin punch biopsy that can be used as early as the second day after birth to detect the condition.Healio spoke to John “Jay” Gargus, MD, PhD, founding scientist and....

01/20/2026

It’s here! Earlier insights. Earlier action.

Introducing ASD Insight™: the first biology-based test that can detect autism risk at birth.

neuroqure.com?utm_source=facebook&utm_campaign=launch_organic&utm_medium=social

A new chapter starts today. 💙

Address

5 Mason
Irvine, CA
92618

Alerts

Be the first to know and let us send you an email when NeuroQure posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NeuroQure:

Share